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Abstract
Background: The number of patients with yeast infection has increased during the last years. Also
the variety of species of clinical importance has increased. Correct species identification is often
important for efficient therapy, but is currently mostly based on phenotypic features and is
sometimes time-consuming and depends largely on the expertise of technicians. Therefore, we
evaluated the feasibility of PCR-based amplification of the internally transcribed spacer region 2
(ITS2), followed by fragment size analysis on the ABI Prism 310 for the identification of clinically
important yeasts.
Results: A rapid DNA-extraction method, based on simple boiling-freezing was introduced. Of the
26 species tested, 22 could be identified unambiguously by scoring the length of the ITS2-region.
No distinction could be made between the species Trichosporon asteroides and T. inkin or between
T. mucoides and T. ovoides. The two varieties of Cryptococcus neoformans (var. neoformans and var.
gattii) could be differentiated from each other due to a one bp length difference of the ITS2
fragment. The three Cryptococcus laurentii isolates were split into two groups according to their
ITS2-fragment lengths, in correspondence with the phylogenetic groups described previously. Since
the obtained fragment lengths compare well to those described previously and could be exchanged
between two laboratories, an internationally usable library of ITS2 fragment lengths can be
constructed.
Conclusions: The existing ITS2 size based library enables identification of most of the clinically
important yeast species within 6 hours starting from a single colony and can be easily updated when
new species are described. Data can be exchanged between laboratories.
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Background
Rapid and correct identification of the different clinically
relevant yeast species has become more important be-
cause of several reasons. During the last decade, the im-
pact and frequency of yeast infections has gained
importance mainly due to an increased number of immu-
nocompromised patients [1]. Furthermore, an increasing
number of non-C. albicans yeast species are considered as
potential agents of clinical infections [2]. Finally, the dif-
ferences in susceptibility towards antifungal agents be-
tween the different species make that rapid yeast
identification can be used as a first indication for efficient
treatment.
Phenotypic identification relies on cell and colony mor-
phology and on biochemical characteristics, but this ap-
proach is not always fully discriminative, may be time-
consuming and requires specific expertise of the techni-
cians [3]. Therefore several groups have explored the pos-
sibilities of PCR-based techniques for the differentiation
between different yeast species. The use of species specific
probes [4,5] or molecular beacons [6] resulted in very sen-
sitive and very specific techniques but remains restricted
to the species for which the probes are designed for. A
more broadly applicable approach is based on PCR with
universal fungal primers (directed towards conserved re-
gions in the ribosomal region) and followed by either re-
striction analysis [7], sequencing [8] or size determination
of the amplified fragment(s) [9,10].
Here we report an evaluation and extension of the tech-
nique published by Turenne et al.[9], whereby the rRNA
Internally Transcribed Spacer Region 2 (ITS2), i.e. the re-
gion in between the fungal 5.8S and 28S rRNA genes, is
amplified and its length is determined by fragment analy-
sis on an ABI Prism 310 capillary electrophoresis system.
Turenne et al.[9] showed that the length of the ITS2-spacer
region was characteristic for most species and that it was
identical for all strains within a species, although only a
limited number of strains was used per species. By using
one fluorescently labeled primer, the size of the amplicon
can be determined by electrophoresis on an ABI Prism
310 capillary apparatus, which provides with the one base
pair resolution that is needed to differentiate between
ITS2-fragment lengths of closely related species. In this
study, we also evaluated a simpler and more rapid DNA-
extraction method and we applied ITS2-PCR on ABI Prism
310 on more strains and species than in the original pub-
lication.
Results
Using DNA-extraction based on boiling/freezing of the
yeast colonies, the ITS2-PCR fragment could be amplified
easily from all yeast strains. An initial ITS2 size based li-
brary was constructed using a panel of reference strains,
belonging to most of the clinically important species (Ta-
ble 1).
When amplifying the ITS2-PCR fragment, care was taken
to label the same primer as used by Turenne et al.[9] and
to use the same HEX-label, in order not to introduce arte-
factual length differences. Still, when the obtained frag-
ment lengths were compared with those of Turenne et
al.[9], differences were observed (Table 2). These could be
explained by our use of dTTP, compared to the use of
dUTP in the original publication [9]. Unpublished frag-
ment lengths obtained at the laboratory of Turenne when
using dTTP were in agreement with our findings (Turenne,
pers. comm.).
Table 1: Reference strains used in this study
Species Reference strains*
Blastoschizomyces 
capitatum
IHEM 5091
Candida albicans IHEM 3242, IHEM 3731, IHEM 3740, IHEM 
6440
C. dubliniensis IHEM 14280
C. glabrata IHEM 4210, IHEM 4566, IHEM 5573, IHEM 
9556
C. guilliermondii IHEM 1067, IHEM 1879, IHEM 3283
C. humicola AZB 98-043
C. kefyr IHEM 4211, IHEM 4593, IHEM 5556
C. krusei IHEM 4562, IHEM 5579, IHEM 6387
C. lipolytica HHR A101315
C. lusitaniae IHEM 4593, IHEM 10293, IHEM 14663
C. norvegensis HHR A211294
C. parapsilosis IHEM 1001, IHEM 2052, IHEM 2305, IHEM 
3270
C. tropicalis IHEM 4222, IHEM 4666, IHEM 5609, IHEM 
12085
Cryptococcus albidus IHEM 3267, IHEM 4786, IHEM 6895
C. laurentii IHEM 895, IHEM 5515
C. neoformans var. gattii IHEM 4170
C. neoformans var. 
neoformans
IHEM 4165, IHEM 4171
Geotrichum candidum IHEM 6284
Malassezia furfur IHEM 3697
Saccharomyces 
cerevisiae
IHEM 3962, IHEM 14402, IHEM 14542, 
IHEM 17539
Trichosporon asahii IHEM 9334, IHEM 17910
T. asteroides IHEM 10214
T. inkin IHEM 5824
T. mucoides IHEM 13920
T. ovoides IHEM 17913
*: IHEM: strains from the BCCM/IHEM Culture Collection, Mycology 
Section, Scientific Insitute of Public Health, Brussels, Belgium; HHR: 
Heilig Hart Ziekenhuis, Roeselare, Belgium, AZB: St. Jan Akademisch 
Ziekenhuis, Bruges, Belgium.BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/21
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Table 2: Overview of the different ITS2-fragment lengths observed and of the number of strains identified by means of ITS2-PCR.
Species Number of 
strains tested 
(number used 
for calcula-
tion of the 
average 
length)
ITS2-fragment length (bp), calculated by capil-
lary electrophoresis
Previously 
published 
lengths 
(bp)*[9]
Fragment 
lengths (bp) 
derived from 
Genbank 
sequences
Genbank 
accession 
number of 
sequences 
used
Average Range Standard 
deviation
Blastoschizomy-
ces capitatum
1 250.7 248 251 AF455443
Candida albicans 116 (19) 281.6 281.0 – 282.6 0.37 279 284 AF217609
C. dubliniensis 1 286.3 289 AF218993
C. glabrata 94 (12) 362.6 362.4 – 362.8 0.15 360 365 AF218994
C. guilliermondii 8 323.2 322.7 – 324.2 0.46 321 325 AF218996
C. humicola 1 295.8
C. kefyr 7 375.5 375.4 – 375.8 0.17 372 378 AF218997
C. krusei 10 (2) 285.3 285.2 – 285.4 0.13 282 294 L47113
C. lipolytica 3 (2) 180.6 179.9 – 181.1 0.62 190 AF218983
C. lusitaniae 9 (4) 200.3 200.2 – 200.4 0.10 199 204 AF218970
C. norvegensis 3 (2) 267.1 266.6 – 267.1 0.62 318 AF333096
C. parapsilosis 36 (12) 254.1 253.5 – 255.4 0.60 251 259 U10989
C. rugosa 1 215.0 214.8 – 215.1 0.10 223 AF218971
C. tropicalis 34 (28) 270.6 269.3 – 271.2 0.61 269 272 273 274 AF219000 
AF219001 
AF218992
Cryptococcus 
albidus
3 353.3 352.4 – 354.7 1.26 350 353 AF218972
C. laurentii (envi-
ronmental)
2 272.1 271.9 – 272.3 0.26 275 AF218974
C. laurentii (clini-
cal)
1 307.9 306 310 AJ421006
C. neoformans 
var. neoformans
8 (4) 318.3 318.0 – 318.6 0.29 315 320 AF218975
C. neoformans 
var. gattii
1 320.0 321 AF196312
Dekkera bruxel-
lensis
1 261.8 263 AF043502
Geotrichum can-
didum
3 (1) 193.4 192 195 AF157596
Malassezia furfur 1 494.4 500 AF246896
Saccharomyces 
cerevisiae
35 (25) 366.6 365.1 – 368.5 0.89 363 365 366 367 AF219005 
AF219006 
AF219007
Trichosporon 
asahii
2 301.0 300.8–301.4 0.50 304 AB018014
T. asteroides 1 298.6 304 AF444416
T. inkin 1 298.7 304 AF444420
T. mucoides 1 297.2 297 AF444423
T. ovoides 1 297.5 303 AF444439
*: Values obtained by using dUTP instead of dTTP for the PCR-based amplification reaction [9].BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/21
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The reproducibility of ITS2-PCR is apparent from Table 2.
For example, for 19 C. albicans strains tested, the observed
fragment sizes ranged between 281.0 bp and 282.6 bp
(with an average value of 281.6 bp and a SD of 0.4 bp).
Table 2 presents the ITS2-lengths observed for the differ-
ent species and reference strains tested.
In one laboratory, we observed in a reproducible manner
a smaller sized peak with lower intensity for half of the
strains and for more than half of the species. An example
is shown in Figure 1 for C. glabrata. However, using the
same DNA-extracts, primer batch, commercially prepared
PCR mixture and thermal cycling protocol, this additional
fragment could not be observed in a second laboratory.
When the primers of the second laboratory were used in
the first laboratory, the additional fragments were ob-
served again. The only technical difference noticed be-
tween both laboratories were the thermal cyclers.
Of the 26 species, 22 could be identified unambiguously
by scoring the length of the ITS2-region. In the genus Tri-
chosporon however, no distinction could be made between
the species T. asteroides and T. inkin, since the ITS2-frag-
ment length is approximately 298.6 bp for both species,
and between the species T. mucoides and T. ovoides, which
both have an ITS2-fragment of approximately 297.5 bp.
Also the two varieties of Cryptococcus neoformans (var. neo-
formans and var. gattii) could be differentiated from each
other due to a one bp length difference of the ITS2 frag-
ment, although these findings should be further con-
firmed by inclusion of more strains.
Figure 1
The ITS2-PCR fragment lengths observed for 10 Candida species (GeneScan Analysis screen, ABI Prism 310,
Applied Biosystems).BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/21
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The three C. laurentii isolates were split into two groups
according to the ITS2-fragment length. The clinical isolate
(IHEM, 1296, human mouth) had a fragment of 307.9
bp, while the two environmental isolates (from filter
board of humidifier system (IHEM 0895) and from in-
door air (IHEM 5515)), had an ITS2 length of 272.1 bp.
The ATCC 18803 type strain, an isolate from palm wine,
was found to yield a fragment of 306 base pairs, using
dUTPs [9]. Sequencing of the ITS2 of the three strains
identified them all as C. laurentii. Cluster analysis with
Genbank sequences, published recently [11], revealed
that the clinical isolate (IHEM 1296, Genbank AJ421004)
clustered most closely to the type strain in Sugita's phylo-
genetic group I [11], in correspondence with the ITS2-PCR
results, whereas the environmental strains (IHEM 0895:
Genbank AJ421005 and IHEM 5515: Genbank
AJ421006) clustered in phylogenetic group II, which con-
tained mostly environmental strains and one isolate from
the bronchi of a lung patient (Figure 1).
After construction of the library, a large collection of clin-
ical isolates was identified both with ITS2-PCR and by
phenotypic means, using Albicans ID plate (BioMérieux,
Marcy-l'Etoile, France) and/or Auxacolor (Sanofi-Pasteur,
Marnes-la-Coquette, France) and/or cellular and colony
morphology. The number of additional strains tested for
each species is listed in Table 2. Two isolates could initial-
ly not be identified by ITS2-PCR, because the observed
ITS2-fragment lengths were not present in the library. Ac-
cording to biochemical and ITS2-sequencing data, the first
isolate belonged to the species Candida rugosa, a species
initially lacking in the library. The ITS2 fragment length
value of 215.0 bp for C. rugosa was added to the database.
Another isolate from a hematology patient and from syr-
up present in his room, had a previously not observed ITS-
length of 261.8 bp and sequencing revealed an identity as
Dekkera (Brettanomyces) bruxellensis, a species that had not
been included in the library initially. The ITS2 fragment
lengths obtained for 25 S. cerevisiae strains ranged be-
tween 365.1 and 368.5 bp (average 366.7 bp., SD 0.89
bp.), but no misidentifications occurred.
Clear differences could be observed between the length of
the ITS2-region as derived from published sequences (the-
oretical length) and as calculated after capillary electro-
phoresis (estimated length) (Table 2). Although the
estimated length is highly reproducible, it is consistently
shorter than the theoretical length (except for Blastoschizo-
myces capitatum, C. albidus, T. mucoides and S. cerevisiae,
where it is identical). A maximal difference of 9 bp was
observed for C. krusei. For S. cerevisiae, the range of 3 bp
observed for the estimated ITS2 lengths was also present
in the theoretical lengths derived from the Genbank se-
quences.
Discussion
ITS2-PCR followed by size determination of the fragment
length by capillary electrophoresis has been described as a
possible tool for the identification of yeasts by Turenne et
al. [9] and by Chen et al. [10]. The latter authors amplified
a 50 bp longer stretch of the ITS2 region than did the
former. Since ITS2-PCR fragments of different species may
differ by only one bp, highly reproducible high resolution
electrophoresis as provided by capillary electrophoresis
on ABI Prism 310 is necessary.
In order to increase the speed of this approach we used a
simple and rapid boiling/freezing based DNA extraction
protocol, which proved to be highly efficient. Together,
DNA-extraction, PCR and capillary electrophoresis took
3.5 hours. Thus, the total time to identification is 3.5
hours for the first sample, added with 45 minutes for each
following sample, when using a single capillary apparatus
like the ABI Prism 310. When a 16 capillary apparatus is
used (ABI Prism 3100), the first 16 strains can be identi-
fied within 3.5 hrs. Besides speed and high discriminatory
power, another advantage of this approach is that newly
recognized species or species not yet present in the data-
base can be added after appropriate initial identification,
whereafter their identification by means of ITS2-PCR is
straightforward. Given the identical values we obtained
with unpublished ones by Turenne et al. [pers. comm.], it
can be assumed that the data are exchangeable between
laboratories, as also has been shown for other DNA-fin-
gerprints obtained on ABI Prism 310 machines [12,13].
The lengths obtained for the amplified ITS2 fragments in
two different laboratories during this study were indeed
perfectly comparable. The only difference was an appar-
ently artefactual additional peak of lower size and lower
intensity in one laboratory, never observed in the other
laboratory.
The variety of species that can be identified can be expand-
ed and this can be achieved in a joint effort between lab-
oratories. Moreover, laboratories not having constructed
such a database their selves, can compare the data of their
unknowns to a publicly available database, like the one
published here. Care should be taken to use the same
primer labeled in the same manner and to use the same
size markers and size standard files (available upon re-
quest) to normalize the capillary electrophoresis runs,
since minor differences between these can introduce mi-
gration and normalization differences.
The differences between the theoretical length (as ob-
tained after counting the bases of the available ITS2 se-
quences) and the calculated length (as obtained after
capillary electrophoresis) can be explained by the fact that
electrophoretic migration is also partially sequence de-
pendent, such that the calculated length will not alwaysBMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/21
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match exactly the theoretical length. However, as long as
the calculated length is reproducible from run to run and
between laboratories, this observation poses no problem
for the purpose of identification. Only for one species (C.
norvegensis) the obtained length in this study was com-
pletely different from the one derived from the published
GenBank sequence (Table 2).
Using ITS2-PCR, identification to species level is very effi-
cient for the genera Candida and Cryptococcus, while four
species of the five tested for the genus Trichosporon could
be split into two groups only. However, the current taxon-
omy of Trichosporon needs further refinement, and our
findings should be corroborated on additional, taxonom-
ically well characterized strains.
The two different ITS2 lengths found for the C. laurentii
strains in this study appear to correspond with a recently
described phylogenetic subdivision within this species,
that was based on the sequences of the 28S rRNA and of
the ITS1 and ITS2 regions [11]. Thus, it appears that both
groups can be differentiated simply by determination of
the ITS2 length and that a distinction between environ-
mental and clinical isolates might be possible. Although
the ITS2-fragment lengths range between 365.1 and 368.5
basepairs for S. cerevisiae strains, identification remains
possible since these fragment lengths are not encountered
in other clinically important yeast species studied thus far.
When methods are used that are suitable for DNA-extrac-
tion directly from clinical specimens, it should be possible
to detect and identify at once the different species that
may be simultaneously present, since the fingerprint will
consist of ITS2 fragments of different lengths, correspond-
ing to the different ITS2-lengths for each species. Howev-
er, when applied for direct detection, the minor peaks, as
observed in one of the laboratories, could lead to prob-
lems in assessing the number and nature of the species
present.
When ITS2-primers are labeled differently from e.g. tRNA-
PCR primers [12–14], electrophoresis of bacterial tRNA-
PCR and fungal ITS2-PCR can be carried out simultane-
ously.
Materials and Methods
Strains
A collection of 53 culture collection strains (Table 1) and
90 phenotypically well-identified strains, representing 24
species, was used to evaluate the technique and to set up
an initial database. The technique and database were eval-
uated by identification of 242 clinical isolates from four
Belgian hospitals (Ghent University Hospital, Heilig Hart
Ziekenhuis Roeselare, Akademisch Ziekenshuis VUB Jette
and Akademisch Ziekenhuis St. Jan Bruges). In total, 385
strains belonging to 26 species (Table 2) were included.
DNA extraction
A boiling-freezing protocol was used for DNA-extraction.
A 1 µl loopful of growth on Sabouraud agar (Becton Dick-
inson, Maryland, Ca.) was suspended in 500 µl distilled
water and heated for 15 minutes at 95°C, immediately fol-
lowed by freezing at -70°C for at least 15 minutes. Before
adding the DNA-extract to the PCR mix, the samples were
thawed at room temperature, and shortly centrifuged to
pellet the cell debris still present in the extract.
ITS2-PCR
The ITS2-region was amplified with the following prim-
ers: ITS86 (GTG AAT CAT CGA ATC TTT GAA C-HEX)
(fluorescently labeled) and ITS4 (TCC TCC GCT TAT TGA
TAT GC) [9]. The ITS86 primer was used as a mixture of
10% fluorescently labeled and 90% non-fluorescently la-
beled primer in order to avoid out of range peak heights.
The PCR reaction mix contained 12.5 µl Qiagen Master-
mix (Qiagen, Hilden, Germany), 0.5 µM of each primer,
2.5 µl of the DNA extract and 9 µl of sterile distilled water
in a final volume of 25 µl. The thermal cycling was carried
out according to the following protocol: 5 min at 94°C, 30
cycli of 1 min at 94°C, 1 min at 55°C and 1 min at 72°C
and a final extension of 7 min at 72°C, followed by cool-
ing at 4°C.
Capillary electrophoresis
The capillary electrophoresis apparatus used was the ABI
Prism 310 Genetic Analyser (Applied Biosystems, Foster
City, Ca.). Electrophoresis was done in a single capillary,
filled with liquid polymer (POP-4: Performance Opti-
mized Polymer, Applied Biosystems), which was auto-
matically replaced after every electrophoresis run.
Preparation of the sample before electrophoresis consist-
ed of adding 1 µl of ITS2-PCR product to 12.5 µl of elec-
trophoresis mixture (0.1 µl HD 400 marker, 0.3 µl of
ROX-500 marker and 12.1 µl of deionized formamide, all
from Applied Biosystems). The double stranded ITS2-PCR
fragments were denatured by heating this mixture for 2
minutes at 95°C, followed by immediate cooling on ice.
Electrophoresis of each sample was carried out at 60°C
and at 15 kV, during 35 min. The Gene Scan analysis soft-
ware (Applied Biosystems) was used to derive the frag-
ment length of the HEX-labeled DNA-fragments using the
known fragment lengths of the ROX-labeled marker
peaks. The results were presented in a table indicating
length and intensity of the observed fragments. BaseHop-
per software, described previously [12,13] and freely
available upon request was used to quickly compare the
obtained ITS2-fragment lengths with those of the ITS2-da-
tabase.BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/21
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Sequencing of the ITS2 region
After amplification of the ITS2 region, the amplicon was
purified using the Qiaquick PCR purification kit, accord-
ing to the manufacturer's instructions. Cycle sequencing
was performed using the Ready-reaction mix (ABI Prism
Bigdye Terminator Cycle Sequencing kit, Applied Biosys-
tems) according to the manufacturer's instructions. Anal-
ysis of the sequencing products was done on the ABI
Prism 310 capillary (Applied Biosystems). Assembly of se-
quence fragments and editing was done with GeneBase
(Applied Maths, St. Martens Latem, Belgium). The ob-
tained ITS2 sequences were compared to all known se-
quences in the Genbank by use of Blast 2.0 (National
Center for Biotechnology Information, Bethesda, Md.  [ht-
tp://www.ncbi.nlm.nih.gov/BLAST/]).
Cluster analysis and dendrogram construction of ITS2 se-
quences
Comparative sequence analysis was performed by using
the GeneBase software package (Applied Maths, St. Mar-
tens Latem, Belgium), as described previously [15]. First,
pair wise alignment using UPGMA was carried out with a
gap penalty of 100 %, a unit gap cost of 20 % and an am-
biguity cost of 50 % of the mismatch cost. Subsequently,
global alignment – with C. neoformans ATCC 90113 (Gen-
bank AB034643) used as the outgroup – was carried out
on the region between 26 and 205 bp of the ITS2 region
of C. neoformans, with costs as above. Finally, a similarity
matrix of the aligned sequences was constructed by global
alignment homology calculation and a gap penalty of 20
%. The neighbour-joining method was used to construct
the dendrogram based on this similarity matrix. Bootstrap
(n=100) values were calculated.
Figure 2
Dendrogram of ITS2 sequences of Cryptococcus laurentii, C. albidus and C. neoformans. Numbers on branches indi-
cate bootstrap value. Species name, phylogenetic group according to Sugita et al.[11], strain number, GenBank accession
number (and ITS2-length in bp) are indicated.BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/21
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